Portable Oxygen Concentrators Market to Reach USD 6.46 Billion by 2033 at 12.1% CAGR; North America Leads with 38.9% Share - Key Players: Inogen, Inc., Koninklijke Philips N.V., CAIRE Inc.

The global portable oxygen concentrators market reached USD 2.60 billion in 2025 and is expected to reach USD 6.46 billion by 2033, growing at a CAGR of 12.1% during the forecast period from 2026 to 2033. The market is witnessing rapid growth driven by the increasing prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, along with the rising geriatric population worldwide. Growing demand for home healthcare solutions, increasing preference for portable and lightweight respiratory support devices, and rising awareness regarding long-term oxygen therapy are further accelerating market expansion. In addition, the growing shift toward patient-centric and home-based treatment approaches is significantly boosting adoption across both developed and emerging healthcare markets.

Market growth is strongly supported by continuous advancements in portable oxygen delivery technologies, including compact designs, longer battery life, smart monitoring features, and quieter operation systems. Medical device manufacturers are significantly increasing investments in next-generation portable oxygen concentrators focused on improving mobility, convenience, and patient comfort. In recent years, rising healthcare expenditure, expanding telehealth and remote patient monitoring services, and increasing demand for post-hospital respiratory care have further strengthened market growth. Furthermore, technological innovations such as pulse dose oxygen delivery, wearable oxygen systems, and IoT-enabled respiratory monitoring platforms are enhancing treatment efficiency and accessibility. With ongoing innovation in respiratory care technologies, growing healthcare investments, and increasing demand for home-based oxygen therapy solutions, the portable oxygen concentrators market is poised for sustained and transformative growth.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/portable-oxygen-concentrators-market?sai-v

Key Developments
February 2026: Rising adoption of lightweight and smart portable oxygen concentrators across North America and Europe improved mobility, remote monitoring, and home-based respiratory care management for chronic disease patients.

January 2026: Increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea globally accelerated demand for portable oxygen concentrators in homecare and ambulatory settings.

December 2025: Growing technological advancements in battery efficiency, compact device design, and pulse flow delivery systems enhanced portability and patient convenience in oxygen therapy applications.

November 2025: Expansion of home healthcare infrastructure and rising preference for non-hospital respiratory care solutions across Asia-Pacific and Europe supported increased adoption of portable oxygen concentrators.

October 2025: Increasing investments by medical device manufacturers in next-generation portable oxygen concentrator technologies accelerated innovation in continuous flow and connected respiratory care systems.

September 2025: Rising awareness regarding respiratory health and long-term oxygen therapy across emerging economies improved accessibility and utilization of portable oxygen concentrators among elderly populations.

August 2025: Growing adoption of portable oxygen concentrators for travel and active lifestyle support strengthened demand for FAA-approved and compact respiratory devices globally.

July 2025: Increasing focus on personalized respiratory care and digital health integration across North America and Europe improved patient monitoring capabilities through app-connected oxygen concentrator systems.

June 2025: Expansion of online and offline distribution channels in developing countries improved availability of affordable portable oxygen concentrators for long-term respiratory therapy patients.

Key Players
Inogen, Inc. | Koninklijke Philips N.V. | Pure O2 Ltd | Belluscura | BPL Medical Technologies | GCE Group | Timago | CAIRE Inc. | ResMed | Invacare Corporation | Others

Key Highlights
Inogen, Inc. - Holds an 18.4% share, driven by its portable oxygen concentrator technologies, lightweight respiratory care devices, and strong direct-to-consumer distribution network.

Koninklijke Philips N.V. - Holds a 16.1% share, supported by advanced home respiratory care solutions, integrated oxygen therapy systems, and strong global healthcare infrastructure.

Pure O2 Ltd - Holds a 9.3% share, fueled by portable oxygen equipment offerings, growing adoption in home healthcare, and expanding respiratory support product availability.

Belluscura - Holds an 8.2% share, driven by innovative portable oxygen concentrator platforms, compact device designs, and increasing focus on patient mobility solutions.

BPL Medical Technologies - Holds a 7.5% share, supported by diversified respiratory care equipment, affordable oxygen therapy technologies, and strong market presence across emerging economies.

GCE Group - Holds a 6.8% share, powered by medical gas control technologies, oxygen therapy delivery systems, and strong industrial and healthcare distribution capabilities.

Timago - Holds a 5.4% share, driven by respiratory support devices, rehabilitation equipment expertise, and growing penetration in homecare applications.

CAIRE Inc. - Holds a 10.6% share, fueled by advanced oxygen concentrator technologies, strong portable oxygen solutions portfolio, and expanding chronic respiratory care adoption.

ResMed - Holds a 6.1% share, supported by connected respiratory care technologies, home oxygen therapy integration, and strong expertise in sleep and pulmonary care.

Invacare Corporation - Holds a 4.7% share, driven by durable home healthcare equipment, oxygen therapy systems, and expanding elderly care product demand.

Others - Hold a combined 6.9% share, comprising regional manufacturers and emerging respiratory care companies focusing on portable, affordable, and smart oxygen therapy technologies.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=portable-oxygen-concentrators-market?sai-v

Market Drivers

Rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and sleep apnea is significantly driving demand for portable oxygen concentrators globally.

Increasing geriatric population and growing incidence of age-related respiratory disorders are accelerating the adoption of portable oxygen therapy devices.

Growing preference for home healthcare and remote patient care is boosting the demand for lightweight and portable oxygen concentrators with enhanced mobility features.

Technological advancements including compact designs, longer battery life, smart connectivity, and quieter operation are improving patient convenience and treatment efficiency.

Increasing awareness regarding long-term oxygen therapy and rising acceptance of portable medical devices are supporting market expansion worldwide.

Growing healthcare investments and expansion of respiratory care infrastructure across emerging economies are strengthening access to oxygen therapy solutions.

Rising demand for mobility-friendly oxygen therapy devices for travel and active lifestyles is further propelling adoption of portable oxygen concentrators.

Industry Developments

Rapid advancements in lightweight and compact portable oxygen concentrators improving patient mobility and convenience.

Increasing development of smart oxygen concentrators integrated with mobile applications and remote monitoring capabilities.

Growing adoption of pulse flow technology due to improved energy efficiency, portability, and longer battery performance.

Expansion of telehealth integration and connected respiratory care solutions enabling remote patient management and therapy optimization.

Rising investments by manufacturers in advanced filtration systems, noise reduction technologies, and durable battery systems to enhance device performance.

Strategic collaborations between medical device manufacturers, respiratory care providers, and healthcare institutions to strengthen product distribution and accessibility.

Continuous focus on safety improvements and regulatory compliance following increasing scrutiny on oxygen concentrator performance and reliability standards.

Regional Insights

North America 38.9% share: "Leads the market due to advanced healthcare infrastructure, high prevalence of respiratory diseases, favorable reimbursement policies, and strong adoption of home healthcare solutions."

Europe 27.4% share: "Growth supported by rising aging population, increasing respiratory disease burden, and expanding adoption of portable home-based oxygen therapy devices."

Asia Pacific 23.6% share: "Fastest-growing region driven by improving healthcare infrastructure, rising pollution levels, increasing respiratory disorders, and growing healthcare investments in countries such as China and India."

Latin America 5.4% share: "Emerging growth supported by increasing awareness regarding respiratory care and improving access to portable medical technologies."

Middle East & Africa 4.7% share: "Gradual growth driven by healthcare modernization initiatives, increasing respiratory disease cases, and expanding availability of oxygen therapy devices."

Speak to our analyst and get customization in the report as per your requirements:https://www.datamintelligence.com/customize/portable-oxygen-concentrators-market?sai-v

Key Segments

➥ By Type

Continuous Flow: Represents the dominant segment, driven by its ability to provide uninterrupted oxygen delivery for patients with severe respiratory conditions and high oxygen requirements.

Pulse Dose: Represents a rapidly growing segment, supported by increasing demand for portable and energy-efficient oxygen delivery systems designed for active and ambulatory patients.

➥ By Application

Asthma: Represents a significant segment, fueled by rising prevalence of chronic respiratory disorders and increasing need for supplemental oxygen support during severe asthma episodes.

COPD: Represents the dominant segment, driven by the growing global burden of chronic obstructive pulmonary disease and increasing long-term oxygen therapy adoption.

Respiratory Distress Syndrome: Represents a growing segment, supported by rising incidence of acute respiratory conditions and expanding use of oxygen therapy in critical care settings.

Others: Represent a niche but expanding segment, including applications in sleep apnea, pneumonia, pulmonary fibrosis, and other respiratory disorders requiring oxygen support.

➥ By End-User

Homecare: Represents the dominant segment, driven by increasing preference for home-based respiratory care, growing geriatric population, and advancements in portable oxygen technologies.

Hospitals: Represent a significant segment, supported by high patient admissions, critical care requirements, and continuous demand for oxygen therapy systems in inpatient settings.

Ambulatory Surgical Centers: Represent a growing segment, fueled by increasing outpatient procedures and rising need for short-term respiratory support solutions.

Others: Represent a niche segment, including emergency care units, rehabilitation centers, and long-term care facilities utilizing oxygen therapy devices.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.